CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,860,000 | +137.8% | 94,082 | +14.0% | 0.01% | +133.3% |
| Q2 2022 | $2,044,000 | +10.8% | 82,501 | +12.2% | 0.00% | +50.0% |
| Q1 2022 | $1,844,000 | -37.8% | 73,551 | -9.6% | 0.00% | -50.0% |
| Q4 2021 | $2,963,000 | +110.0% | 81,370 | -1.4% | 0.00% | +100.0% |
| Q3 2021 | $1,411,000 | +31.0% | 82,491 | +2.5% | 0.00% | +100.0% |
| Q2 2021 | $1,077,000 | -64.6% | 80,459 | +35.4% | 0.00% | -75.0% |
| Q1 2021 | $3,044,000 | -26.2% | 59,407 | -10.9% | 0.00% | -33.3% |
| Q4 2020 | $4,126,000 | +22.2% | 66,638 | +8.2% | 0.01% | +20.0% |
| Q3 2020 | $3,376,000 | -19.5% | 61,613 | -15.5% | 0.01% | -28.6% |
| Q2 2020 | $4,196,000 | +71.4% | 72,923 | +19.7% | 0.01% | +40.0% |
| Q1 2020 | $2,448,000 | +13.9% | 60,932 | +12.1% | 0.01% | +25.0% |
| Q4 2019 | $2,150,000 | +580.4% | 54,374 | +16.7% | 0.00% | +300.0% |
| Q3 2019 | $316,000 | -26.9% | 46,611 | +0.5% | 0.00% | 0.0% |
| Q2 2019 | $432,000 | +4.6% | 46,401 | +56.2% | 0.00% | 0.0% |
| Q1 2019 | $413,000 | +23.7% | 29,704 | -2.9% | 0.00% | 0.0% |
| Q4 2018 | $334,000 | +25.1% | 30,596 | +44.9% | 0.00% | 0.0% |
| Q3 2018 | $267,000 | -9.5% | 21,117 | -5.6% | 0.00% | 0.0% |
| Q2 2018 | $295,000 | -8.1% | 22,367 | -5.1% | 0.00% | 0.0% |
| Q1 2018 | $321,000 | +124.5% | 23,578 | -1.7% | 0.00% | – |
| Q4 2017 | $143,000 | -35.6% | 23,983 | -19.9% | 0.00% | – |
| Q3 2017 | $222,000 | -19.0% | 29,953 | +2.4% | 0.00% | -100.0% |
| Q2 2017 | $274,000 | +28.0% | 29,248 | -0.3% | 0.00% | – |
| Q1 2017 | $214,000 | +1.4% | 29,343 | +3.0% | 0.00% | -100.0% |
| Q4 2016 | $211,000 | +31.1% | 28,475 | +6.6% | 0.00% | – |
| Q3 2016 | $161,000 | +38.8% | 26,722 | +3.0% | 0.00% | – |
| Q2 2016 | $116,000 | +63.4% | 25,946 | -9.4% | 0.00% | – |
| Q1 2016 | $71,000 | -69.4% | 28,635 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $232,000 | +45.0% | 28,635 | +8.0% | 0.00% | 0.0% |
| Q3 2015 | $160,000 | -24.2% | 26,515 | +3.6% | 0.00% | 0.0% |
| Q2 2015 | $211,000 | -26.0% | 25,598 | -32.1% | 0.00% | 0.0% |
| Q1 2015 | $285,000 | +16.3% | 37,713 | +5.0% | 0.00% | 0.0% |
| Q4 2014 | $245,000 | +66.7% | 35,913 | +10.0% | 0.00% | – |
| Q3 2014 | $147,000 | -23.0% | 32,663 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $191,000 | +39.4% | 32,663 | +58.4% | 0.00% | – |
| Q1 2014 | $137,000 | +8.7% | 20,625 | -5.5% | 0.00% | – |
| Q4 2013 | $126,000 | +0.8% | 21,825 | -3.1% | 0.00% | – |
| Q3 2013 | $125,000 | -59.9% | 22,525 | +2.1% | 0.00% | -100.0% |
| Q2 2013 | $312,000 | – | 22,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |